Champions Oncology, Inc. (CSBR): Capital Expenditures
$564.0K
Year ended 2026-04-30
$573.0K
Trailing 12 months to 2026-07-31
-41.9%
3-year compound annual growth
-29.7%
5-year compound annual growth
+5.8%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2026-04-30 | $564.0K | +45.0% | 2026-07-27, From 2025-05-01 |
| 2025-04-30 | $389.0K | -53.5% | 2026-07-27, From 2024-05-01 |
| 2024-04-30 | $836.0K | -70.9% | 2025-07-23, From 2023-05-01 |
| 2023-04-30 | $2.87M | +20.5% | 2024-07-19, From 2022-05-01 |
| 2022-04-30 | $2.38M | -27.3% | 2023-07-24, From 2021-05-01 |
| 2021-04-30 | $3.28M | +47.8% | 2022-07-22, From 2020-05-01 |
| 2020-04-30 | $2.22M | +166.2% | 2021-07-26, From 2019-05-01 |
| 2019-04-30 | $834.0K | -32.1% | 2020-07-28, From 2018-05-01 |
| 2018-04-30 | $1.23M | +60.4% | 2019-07-29, From 2017-05-01 |
| 2017-04-30 | $766.0K | +137.9% | 2018-07-30, From 2016-05-01 |
| 2016-04-30 | $322.0K | +170.6% | 2017-07-28, From 2015-05-01 |
| 2015-04-30 | $119.0K | -49.1% | 2016-07-29, From 2014-05-01 |
| 2014-04-30 | $234.0K | +310.5% | 2015-07-29, From 2013-05-01 |
| 2013-04-30 | $57.0K | -89.0% | 2014-07-28, From 2012-05-01 |
| 2012-04-30 | $519.0K | +510.6% | 2013-07-26, From 2011-05-01 |
| 2011-04-30 | $85.0K | n/a | 2012-07-18, From 2010-05-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Champions Oncology, Inc. (CSBR) | 2026-04-30 | $564.0K | +45.0% |
| Invivyd, Inc. (IVVD) | 2025-12-31 | $155.0K | +10.7% |
| Protalix BioTherapeutics, Inc. (PLX) | 2025-12-31 | $1.64M | +27.8% |
| Vir Biotechnology, Inc. (VIR) | 2025-12-31 | $4.83M | -33.8% |
| Compugen Ltd (CGEN) | 2025-12-31 | $306.0K | +159.3% |
| Recursion Pharmaceuticals, Inc. (RXRX) | 2025-12-31 | $6.47M | -52.8% |
| Autolus Therapeutics plc (AUTL) | 2025-12-31 | $19.04M | -13.7% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $3.83M | -22.8% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $536.0K | -85.8% |
Compare CSBR, IVVD, PLX, VIR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗